URGENT LEGISLATIVE ALERT
from
AMERICAN MEDICAL TECHNOLOGISTS
Tell Your Senators and Representatives to Oppose Including a
20% Beneficiary Co-Payment for Medicare Lab Services
in the Debt Limit Legislation
The Clinical Laboratory Coalition has learned that Congressional budget negotiators are seriously considering imposing an across-the-board 20% beneficiary coinsurance requirement for all Medicare Part B services, including clinical lab tests, as part of a debt ceiling/deficit reduction legislative package.
The lab community has fended-off numerous co-pay proposals in recent years, but this year’s initiative may be the most serious threat yet. If enacted, coinsurance would shift billions in costs to seniors and dramatically reduce labs’ net revenues for Medicare testing because of the cost and difficulty of collecting the copayments.
Call or email your Senators and Representative today and urge them to OPPOSE beneficiary cost-sharing for Medicare lab services. It’s a bad idea, here is why:
http://www.americanmedtech.org/NewsAdvocacy/View/tabid/95/ArticleId/4/URGENT-LEGISLATIVE-ALERT.aspx
